Positive Results From Clinical Study Designed To Evaluate Efficacy Of Circulating Tum
 

Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, today announced positive results from a clinical study conducted by a research group at the Weatherall Institute of Molecular Medicine at Oxford University, a laboratory supported by Cancer Research U.K. (CRUK), the country's leading cancer charity.

More...